JELDROP

What this means for you

This application is over — abandoned 17 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97576367

Mark type

Word mark

Filed

02 Sept 2022

Abandoned

17 Jun 2024

Attorney of record

Joe McKinney Muncy

Goods and services

• Class 005 — Pharmaceuticals: Glaucoma agents; Irrigating solutions for eye use; Medicated eye washes; Eye drops; Ocular pharmaceuticals; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Dermatological pharmaceutical products; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated dermatological preparations and substances; Medicated skin preparation for use in treating wound healing; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Medicated ointments for treating dermatological conditions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin care preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Medicinal creams for skin care; Frostbite salve for pharmaceutical purposes; Poultices; Gelatine for medical purposes; Ointments for wound healing; Sunburn ointments; Acne treatment preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of gel that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for prostatic diseases and conditions; Pharmaceutical preparations for benign prostatic hyperplasia; Pharmaceutical preparations for the treatment and prevention of prostatic diseases and conditions; Pharmaceutical preparations for the treatment and prevention of benign prostatic hyperplasia

Owner

• AiViva Biopharma, Inc., Dover, Kent County,, DE, US

Prosecution history

• 01 Jul 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 01 Jul 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 22 Feb 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 22 Feb 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 15 Dec 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 15 Dec 2023 — FINAL REFUSAL E-MAILED
• 15 Dec 2023 — FINAL REFUSAL WRITTEN
• 12 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 11 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 11 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 07 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 07 Jul 2023 — NON-FINAL ACTION E-MAILED
• 07 Jul 2023 — NON-FINAL ACTION WRITTEN
• 20 Jun 2023 — ASSIGNED TO EXAMINER
• 11 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED